Insulet Corp

PODD

Company Profile

  • Business description

    Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.

  • Contact

    100 Nagog Park
    ActonMA01720
    USA

    T: +1 978 600-7000

    E: [email protected]

    https://www.insulet.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2024

    Employees

    3,000

Insulet Corp News & Analysis

funds

A top-tier small cap fund

Morningstar is confident Dimensional will outperform over the longer-term despite lagging during the market sell-off.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,376.1059.400.71%
CAC 407,274.4819.89-0.27%
DAX 4019,884.7585.11-0.43%
Dow JONES (US)42,840.26498.021.18%
FTSE 1008,084.6120.71-0.26%
HKSE19,720.7031.81-0.16%
NASDAQ19,572.60199.831.03%
Nikkei 22538,987.38285.480.74%
NZX 50 Index12,876.7927.32-0.21%
S&P 5005,930.8563.771.09%
S&P/ASX 2008,125.5058.500.73%
SSE Composite Index3,368.060.01-0.00%

Market Movers